Occudo Quantitative Strategies LP Biocryst Pharmaceuticals Inc Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $134,569 - $182,938	27,022 New	27,022 $161,000
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $133,005 - $168,359	19,110 New	19,110 $134,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $663,142 - $910,207	61,459 New	61,459 $774,000
Q1 2021 May 14, 2021	SELL	$7.37 - $13.61 $641,330 - $1.18 Million	-87,019 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $293,254 - $749,233	87,019 New	87,019 $648,000

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.